Cyclin B1 Recombinant Rabbit Monoclonal Antibody [SU33-03]
Overview
Product Name
Cyclin B1 Recombinant Rabbit Monoclonal Antibody [SU33-03]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic peptide within Human Cyclin B1 aa 384-433 / 433.
Species Reactivity
Human
Validated Applications
WB, IF-Cell, IF-Tissue, IHC-P, IP
Molecular Weight
Predicted band size: 48 kDa
Positive Control
HeLa cell lysate, Jurkat cell lysate, HepG2 cell lysate, human tonsil tissue, human colon carcinoma tissue, human lymph nodes tissue, human breast carcinoma tissue.
Conjugation
unconjugated
Clone Number
SU33-03
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:5,000
-
IF-Cell
-
1:50-1:200
-
IF-Tissue
-
1:50-1:200
-
IHC-P
-
1:50-1:400
-
IP
-
Use at an assay dependent concentration.
Target
Function
G2/mitotic-specific cyclin-B1 is a protein that in humans is encoded by the CCNB1 gene. Cyclin B1 is a regulatory protein involved in mitosis. The gene product complexes with p34 (Cdk1) to form the maturation-promoting factor (MPF). Cyclin B1 contributes to the switch-like all or none behavior of the cell in deciding to commit to mitosis. Its activation is well-regulated, and positive feedback loops ensure that once the cyclin B1-Cdk1 complex is activated, it is not deactivated. Cyclin B1-Cdk1 is involved in the early events of mitosis, such as chromosome condensation, nuclear envelope breakdown, and spindle pole assembly. Once activated, cyclin B1-Cdk1 promotes several of the events of early mitosis. The active complex phosphorylates and activates 13S condensin, which helps to condense chromosomes. Another important function of the cyclin B1-Cdk1 complex is to break down the nuclear envelope. Phosphorylation of the lamins by cyclin B1-Cdk1 causes them to dissociate, compromising the structural integrity of the nuclear envelope so that it breaks down. The destruction of the nuclear envelope is important because it allows the mitotic spindle to access the chromosomes.
Background References
1. Nabti I et al. Dual-mode regulation of the APC/C by CDK1 and MAPK controls meiosis I progression and fidelity. J Cell Biol 204:891-900 (2014).
2. Penas C et al. Casein kinase 1d-dependent Wee1 protein degradation. J Biol Chem 289:18893-903 (2014).
Sequence Similarity
Belongs to the cyclin family. Cyclin AB subfamily.
Post-translational Modification
Ubiquitinated by the SCF(NIPA) complex during interphase, leading to its destruction. Not ubiquitinated during G2/M phases.; Phosphorylated by PLK1 at Ser-133 on centrosomes during prophase: phosphorylation by PLK1 does not cause nuclear import. Phosphorylation at Ser-147 was also reported to be mediated by PLK1 but Ser-133 seems to be the primary phosphorylation site.
Subcellular Location
Cytoplasm, Nucleus.
UNIPROT
Synonyms
CCNB 1 antibody
CCNB antibody
ccnb1 antibody
CCNB1_HUMAN antibody
Cyclin B1 antibody
G2 mitotic specific cyclin B1 antibody
G2/mitotic-specific cyclin-B1 antibody
Images
-
Western blot analysis of Cyclin B1 on different lysates with Rabbit anti-Cyclin B1 antibody (ET1608-27) at 1/5,000 dilution.
Lane 1: HeLa cell lysate
Lane 2: Jurkat cell lysate
Lane 3: HepG2 cell lysate
Lysates/proteins at 15 µg/Lane.
Predicted band size: 48 kDa
Observed band size: 55 kDa
Exposure time: 3 minutes 10 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1608-27) at 1/5,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:50,000 dilution was used for 1 hour at room temperature. -
Immunohistochemical analysis of paraffin-embedded human tonsil tissue using anti-Cyclin B1 antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 8.0-8.4) for 20 minutes.The tissues were blocked in 5% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1608-27, 1/50) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.
-
Immunohistochemical analysis of paraffin-embedded human colon carcinoma tissue with Rabbit anti-Cyclin B1 antibody (ET1608-27) at 1/400 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1608-27) at 1/400 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human lymph nodes tissue with Rabbit anti-Cyclin B1 antibody (ET1608-27) at 1/400 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1608-27) at 1/400 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
Immunohistochemical analysis of paraffin-embedded human breast carcinoma tissue with Rabbit anti-Cyclin B1 antibody (ET1608-27) at 1/400 dilution.
The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes. The tissues were blocked in 1% BSA for 20 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (ET1608-27) at 1/400 dilution for 1 hour at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX. -
☑ Knockdown (KD)
All lanes: Western blot analysis of CCNB1 with anti-CCNB1 antibody[SU33-03] (ET1608-27) at 1:500 dilution.
Lane 1: Wild-type Hela whole cell lysate (10 µg).
Lane 2: CCNB1 knockdown Hela whole cell lysate (10 µg).
ET1608-27 was shown to specifically react with CCNB1 in wild-type Hela cells. Weakened bands were observed when CCNB1 knockdown samples were tested. Wild-type and CCNB1 knockdown samples were subjected to SDS-PAGE. Proteins were transferred to a PVDF membrane and blocked with 5% NFDM in TBST for 1 hour at room temperature. The primary antibody (ET1608-27, 1/500) was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG-HRP Secondary Antibody (HA1001) at 1:300,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of HeLa cells labeling Cyclin B1 with Rabbit anti-Cyclin B1 antibody (ET1608-27) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Cyclin B1 antibody (ET1608-27) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of HePG2 cells labeling Cyclin B1 with Rabbit anti-Cyclin B1 antibody (ET1608-27) at 1/50 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Cyclin B1 antibody (ET1608-27) at 1/50 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
CGF Induces ROS-Mediated Metabolic Reprogramming and Mitochondrial Dysfunction to Suppress Colorectal Cancer Progression
Journal: iScience
DOI: 10.1016/j.isci.2026.115273
IF: 4.1
Application: WB
Reactivity: Human
Publish date: 2026 Mar
-
Aberrant sialic acid metabolism promotes metabolic reprogramming and metastasis in breast cancer
Journal: Frontiers In Oncology
DOI: 10.3389/fonc.2025.1698087
IF: 3.3
Application: WB
Reactivity: Human
Publish date: 2025 Nov
-
Smoking promotes the progression of bladder cancer through FOXM1/CKAP2L axis
Journal: Journal Of Translational Medicine
DOI: 10.1186/s12967-025-06835-2
IF: 7.5
Application: WB
Reactivity: Human
Publish date: 2025 Jul
-
Therapeutic Activation of PPARα Inhibits Transformed Follicular Lymphoma Tumorigenesis via the FOXM1 Signaling Pathway
Journal: International Journal Of Biological Sciences
DOI: 10.7150/ijbs.116437
IF: 10
Application: WB
Reactivity: Human
Publish date: 2025 Aug
-
Quercetin inhibits the cAMP/PKA/CREB/glycolysis axis to exert anti-acute lymphoblastic leukemia effects
Journal: Frontiers In Pharmacology
DOI: 10.3389/fphar.2025.1614973
IF: 4.8
Application: WB
Reactivity: Human
Publish date: 2025 Aug
-
Intelligent drugs based on notch protein remodeling: a defensive targeting strategy for tumor therapy
Journal: Cell Death & Disease
DOI:
IF: 8.1
Application: WB
Reactivity: Human
Publish date: 2024 Sep
-
m6Am sequesters PCF11 to suppress premature termination and drive neuroblastoma differentiation
Journal: Molecular Cell
DOI: 10.1016/j.molcel.2024.10.004
IF: 14.5
Application: WB
Reactivity: Human
Publish date: 2024 Oct
-
IPCEF1: Expression Patterns, Clinical Correlates and New Target of Papillary Thyroid Carcinoma
Journal: Journal Of Cancer
DOI:
IF: 3.3
Application: WB
Reactivity: Human
Publish date: 2024 Nov
-
Trifluoromethyl quinoline derivative targets inhibiting HDAC1 for promoting the acetylation of histone in cervical cancer cells
Journal: European Journal Of Pharmaceutical Sciences
DOI:
IF: 4.6
Application: WB
Reactivity: Human
Publish date: 2024 Jan
-
RNF181 promotes ferroptosis by ubiquitinating HMOX1 to inhibit gastric cancer cell proliferation and chemoresistance
Journal:
DOI:
IF:
Application: WB
Reactivity: Human
Publish date: 2024 Feb
-
Novel inhibitors targeting the PGK1 metabolic enzyme in glycolysis exhibit effective antitumor activity against kidney renal clear cell carcinoma in vitro and in vivo
Journal: European Journal Of Medicinal Chemistry
DOI: 10.1016/j.ejmech.2024.116209
IF: 6
Application: WB
Reactivity: Human
Publish date: 2024 Feb
-
MMP13 as an effective target of an active trifluoromethyl quinazoline compound against osteosarcoma
Journal: Toxicology And Applied Pharmacology
DOI:
IF: 3.3
Application: WB
Reactivity: Human
Publish date: 2024 Dec
-
Network pharmacology and metabolomics elucidate the underlying effects and mechanisms of maackiain against endometrial cancer
Journal: Biochemical And Biophysical Research Communications
DOI:
IF: 2.5
Application: WB
Reactivity: Human
Publish date: 2024 Dec
-
Deguelin inhibits the glioblastoma progression through suppressing CCL2/NFκB signaling pathway
Journal: Neuropharmacology
DOI:
IF: 4.6
Application: WB
Reactivity: Human
Publish date: 2024 Aug
-
Evodiamine Inhibits the Progression of Esophageal Aquamous Cell Carcinoma via Modulating PI3K/AKT/mTOR Pathway
Journal: Preprint And Has Not Been Certified By Peer Review
DOI: 10.21203/rs.3.rs-4133300/v1
IF:
Application: WB
Reactivity: Human,Mouse
Publish date: 2024 Apr
-
An oral phenylacrylic acid derivative suppressed hepatic stellate cell activation and ameliorated liver fibrosis by blocking TGF‐β1 signalling
Journal: Liver International
DOI:
IF: 6.7
Application: WB
Reactivity: Human
Publish date: 2023 Mar
-
A novel L-shaped ortho-quinone analog as PLK1 inhibitor blocks prostate cancer cells in G2 phase
Journal: Biochemical Pharmacology
DOI: 10.1016/j.bcp.2023.115960
IF: 5.8
Application: WB
Reactivity: Human
Publish date: 2023 Dec
-
The HSP90 inhibitor KW-2478 depletes the malignancy of BCR/ABL and overcomes the imatinib-resistance caused by BCR/ABL amplification
Journal: Experimental Hematology & Oncology
DOI:
IF: 5.133
Application: WB
Reactivity: Human
Publish date: 2022 May
-
Cholesterol Sulfate Exerts Protective Effect on Pancreatic β-Cells by Regulating β-Cell Mass and Insulin Secretion
Journal: Frontiers In Pharmacology
DOI:
IF: 4.4
Application: WB
Reactivity: Mouse
Publish date: 2022 Mar
-
Astaxanthin Prevents Tuberculosis-Associated Inflammatory Injury by Inhibiting the Caspase 4/11-Gasdermin-Pyroptosis Pathway
Journal: Evidence-Based Complementary And Alternative Medicine
DOI:
IF: 2.650
Application: WB
Reactivity: Mouse
Publish date: 2022 Dec
-
Identification of the molecular targets and mechanisms of compound mylabris capsules for hepatocellular carcinoma treatment through network pharmacology and bioinformatics analysis
Journal: Journal Of Ethnopharmacology
DOI:
IF: 4.36
Application: WB
Reactivity: Rat
Publish date: 2021 Aug
-
Eriocalyxin B Inhibits Adipogenesis in 3T3‑L1 Adipocytes by Cell Cycle Arrest
Journal: Natural Products And Bioprospecting
DOI:
IF: NA
Application: WB
Reactivity: Mouse
Publish date: 2020 Jun
-
Exopolysaccharide from Cryptococcus heimaeyensis S20 induces autophagic cell death in non-small cell lung cancer cells via ROS/p38 and ROS/ERK signalling
Journal: Cell Proliferation
DOI:
IF: 5.753
Application: WB
Reactivity: Human
Publish date: 2020 Aug
-
Autophagy-dependent cell cycle arrest in esophageal cancer cells exposed to dihydroartemisinin
Journal: Chinese Medicine
DOI:
IF: 2.27
Application: WB
Reactivity: Human
Publish date: 2020 Apr
Products with the same target and pathway
Cyclin B1 Mouse Monoclonal Antibody [C2-F2]
Application: WB,IF-Cell
Reactivity: Human
Conjugate: unconjugated
Cyclin B1 Recombinant Rabbit Monoclonal Antibody [SU33-03] - BSA and Azide free
Application: WB,IF-Cell,IF-Tissue,IHC-P,IP
Reactivity: Human
Conjugate: unconjugated
Cyclin B1 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human,Mouse
Conjugate: unconjugated